Attached files
| file | filename |
|---|---|
| 10-K/A - 10-K/A - JUNIPER PHARMACEUTICALS INC | d174354d10ka.htm |
| EX-31.(I)2 - EX-31(I).2 - JUNIPER PHARMACEUTICALS INC | d174354dex31i2.htm |
Exhibit 31(i).1
Certification Pursuant to Rule 13a-14(a)/15d-14(a)
of the Securities Exchange Act of 1934
I, Frank C. Condella, Jr. certify that:
1. I have reviewed this Amendment No. 1 to Annual Report on Form 10-K of Juniper Pharmaceuticals, Inc.;
2. Based on my knowledge, this report does not contain any untrue statement or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
| /s/ Frank C. Condella, Jr. |
| Frank C. Condella, Jr. |
| President and Chief Executive Officer |
| DATE: April 22, 2016 |